Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

JAK inhibitors might help treat alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Upadacitinib improved multiple immune-related conditions in one patient.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Axitinib treatment turned a man's grey hair back to black.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Nilotinib can cause generalized keratosis pilaris.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may help regrow hair in alopecia areata patients.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.